Drugs / Autologous bone marrow cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00306085 | Apr 2005 → Apr 2006 | peripheral vascular disease | University of Naples | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous bone marrow cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00306085 ↗ |
| Known as | BMCs | “BACKGROUND: Short-term (within 6 weeks follow-up) clinical studies indicate that implantation of bone marrow cells (BMCs) into ischemic limbs may improve peripheral ischemia.” PMID 19050436 ↗ Dec 2008 |
| Modality | Cell therapy | “Cell-based therapy based on bone marrow transplantation is a promising option for patients with critical limb ischemia (CLI).” PMID 20832596 ↗ Sep 2010 |
| Route | Other | “using intra-arterial infusion of autologous bone marrow concentrate” PMID 23375329 ↗ Jan 2013 |